About Lonza Group (OTCMKTS:LZAGY)
Lonza Group Ltd supplies products and services to the pharmaceutical, biotech, and specialty ingredients markets worldwide. The company operates through two segments, Pharma&Biotech and Specialty Ingredients. It offers products and services from the custom development and manufacturing of active pharmaceutical ingredients to dosage forms for the pharma and consumer health, and nutrition industries. The company also provides drinking water sanitizers, nutraceuticals, antidandruff agents, and other personal care ingredients; and agricultural products and advanced coatings and composites, as well as microbial control solutions that combat dangerous viruses, bacteria, and other pathogens. Lonza Group Ltd was founded in 1897 and is headquartered in Basel, Switzerland.
Industry, Sector and Symbol
Industry Tobacco products
Sub-IndustryN/A
SectorMedical
SymbolOTCMKTS:LZAGY
CUSIPN/A
Phone41-61-316-8111
Debt
Debt-to-Equity Ratio0.60%
Current Ratio1.26%
Quick Ratio0.72%
Price-To-Earnings
Trailing P/E Ratio21.05
Forward P/E Ratio20.20
P/E Growth2.02
Sales & Book Value
Annual Sales$5.19 billion
Price / Sales3.60
Cash Flow$1.6575 per share
Price / Cash15.11
Book Value$8.53 per share
Price / Book2.94
Profitability
EPS (Most Recent Fiscal Year)N/A
Net IncomeN/A
Net MarginsN/A
Return on EquityN/A
Return on AssetsN/A
Miscellaneous
Employees10,000
Outstanding Shares744,680,000
Lonza Group (OTCMKTS:LZAGY) Frequently Asked Questions
What is Lonza Group's stock symbol?
Lonza Group trades on the OTCMKTS under the ticker symbol "LZAGY."
How often does Lonza Group pay dividends? What is the dividend yield for Lonza Group?
Lonza Group declared a None dividend on Thursday, February 1st. Investors of record on Wednesday, May 9th will be paid a dividend of $0.261 per share on Tuesday, May 29th. The ex-dividend date is Tuesday, May 8th. View Lonza Group's Dividend History.
Who are some of Lonza Group's key competitors?
Some companies that are related to Lonza Group include Baxter International (BAX), Illumina (ILMN), Takeda Pharmaceutical (TKPYY), Hospital Co. of America (HCA), Regeneron (REGN), Fresenius Medical Care (FMS), Essilor International (ESLOY), Astellas Pharma (ALPMY), McKesson (MCK), Actelion (ALIOF), Shire (SHP), Edwards Lifesciences (EW), Fresenius Medical Care (FME), Alexion Pharmaceuticals (ALXN), Zimmer Biomet (ZBH), Mylan (MYL), Align Technology (ALGN) and AmerisourceBergen (ABC).
Who are Lonza Group's key executives?
Lonza Group's management team includes the folowing people:
- Mr. Richard Ridinger, Chief Exec. Officer (Age 60)
- Mr. Rodolfo Savitzky, Chief Financial Officer (Age 56)
- Mr. Dirk Oehlers, Head of Investor Relations
- Mr. Dominik Werner, Head of Corp. Communications & VP
- Mr. Joseph R. Colleluori, Sr. VP of Corp. Devel.
Has Lonza Group been receiving favorable news coverage?
News coverage about LZAGY stock has been trending somewhat positive recently, according to Accern Sentiment. Accern ranks the sentiment of press coverage by monitoring more than twenty million blog and news sources in real time. Accern ranks coverage of publicly-traded companies on a scale of negative one to one, with scores nearest to one being the most favorable. Lonza Group earned a news impact score of 0.05 on Accern's scale. They also gave media stories about the company an impact score of 46.85 out of 100, meaning that recent press coverage is somewhat unlikely to have an impact on the stock's share price in the near future.
How do I buy shares of Lonza Group?
Shares of LZAGY can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.
What is Lonza Group's stock price today?
One share of LZAGY stock can currently be purchased for approximately $25.0450.
How big of a company is Lonza Group?
Lonza Group has a market capitalization of $18.65 billion and generates $5.19 billion in revenue each year. The company earns $737.83 million in net income (profit) each year or $1.19 on an earnings per share basis. Lonza Group employs 10,000 workers across the globe.
How can I contact Lonza Group?
Lonza Group's mailing address is Muenchensteinerstrasse 38, Basel V8, 4002. The company can be reached via phone at 41-61-316-8111 or via email at [email protected]
MarketBeat Community Rating for Lonza Group (LZAGY)
MarketBeat's community ratings are surveys of what our community members think about Lonza Group and other stocks. Vote "Outperform" if you believe LZAGY will outperform the S&P 500 over the long term. Vote "Underperform" if you believe LZAGY will underperform the S&P 500 over the long term. You may vote once every thirty days.
Lonza Group (OTCMKTS:LZAGY) Price Target and Consensus Rating
(How are Consensus Ratings Calculated?) MarketBeat calculates consensus analyst ratings for stocks using the most recent rating from each Wall Street analyst that has rated a stock within the last twelve months. Each analyst's rating is normalized to a standardized rating score of 1 (sell), 2 (hold), 3 (buy) or 4 (strong buy). Analyst consensus ratings scores are calculated using the mean average of the number of normalized sell, hold, buy and strong buy ratings from Wall Street analysts. Each stock's consensus analyst rating is derived from its calculated consensus ratings score (0-1.5 = Sell, 1.5-2.5 = Hold, 2.5-3.5 = Buy, >3.5 = Strong Buy). MarketBeat's consensus price targets are a mean average of the most recent available price targets set by each analyst that has set a price target for the stock in the last twelve months. MarketBeat's consensus ratings and consensus price targets may differ from those calculated by other firms due to differences in methodology and available data.
1 Wall Street analysts have issued ratings and price targets for Lonza Group in the last 12 months. There are currently 1 buy rating for the stock, resulting in a consensus rating of "Buy."
| Today | 30 Days Ago | 90 Days Ago | 180 Days Ago |
| Consensus Rating: | Buy | Buy | Buy | Buy |
| Consensus Rating Score: | 3.00 | 3.00 | 3.00 | 3.00 |
| Ratings Breakdown: | 0 Sell Rating(s)
0 Hold Rating(s)
1 Buy Rating(s)
0 Strong Buy Rating(s) | 0 Sell Rating(s)
0 Hold Rating(s)
1 Buy Rating(s)
0 Strong Buy Rating(s) | 0 Sell Rating(s)
0 Hold Rating(s)
1 Buy Rating(s)
0 Strong Buy Rating(s) | 0 Sell Rating(s)
0 Hold Rating(s)
1 Buy Rating(s)
0 Strong Buy Rating(s) |
| Consensus Price Target: | N/A | N/A | N/A | N/A |
| Price Target Upside: | N/A | N/A | N/A | N/A |
Lonza Group (OTCMKTS:LZAGY) Consensus Price Target History
Lonza Group (OTCMKTS:LZAGY) Analyst Ratings History
Show:
| Date | Brokerage | Action | Rating | Price Target | Details |
|---|
| 7/19/2017 | Jefferies Group | Upgrade | Hold -> Buy | |  |
(Data available from 4/23/2016 forward)
Lonza Group (OTCMKTS:LZAGY) Dividend History by Quarter
| Announced | Period | Amount | Yield | Ex-Dividend Date | Record Date | Payable Date |
|---|
| 2/1/2018 | None | $0.2610 | | 5/8/2018 | 5/9/2018 | 5/29/2018 |
(Data available from 1/1/2013 forward)
Lonza Group (OTCMKTS LZAGY) Insider Trading and Institutional Ownership History
Institutional Ownership Percentage: 0.23%
Lonza Group (OTCMKTS LZAGY) Insider Trading History
| Transaction Date | Insider Name | Title | Buy/Sell | Number of Shares | Average Share Price | Total Transaction | Shares Held After Transaction | Details |
|---|
(Data available from 1/1/2013 forward)
Lonza Group (OTCMKTS LZAGY) News Headlines
| Source: |
|
| Date | Headline |
|---|
 | Lonza Group (LZAGY) Upgraded at ValuEngine
www.americanbankingnews.com - April 21 at 8:42 AM |
| Comparing British American Tobacco (BTI) & Lonza Group (LZAGY)
www.americanbankingnews.com - April 11 at 7:35 PM |
 | Lonza Opens World's Largest Dedicated Cell and-Gene-Therapy Manufacturing Facility in Pearland, Greater Houston, TX (USA)
finance.yahoo.com - April 10 at 10:06 AM |
| Lonza Group (LZAGY) Upgraded by Zacks Investment Research to Hold
www.americanbankingnews.com - April 5 at 12:57 PM |
| H. Lundbeck A/S- (HLUYY) and Lonza Group (LZAGY) Critical Comparison
www.americanbankingnews.com - April 2 at 3:06 AM |
| Lonza Group (LZAGY) and Turning Point Brands (TPB) Critical Analysis
www.americanbankingnews.com - March 31 at 11:16 PM |
| Lonza Group (LZAGY) Downgraded by Zacks Investment Research
www.americanbankingnews.com - March 25 at 12:49 PM |
 | Global Mycoplasma Testing Market Opportunities 2018: Meridian Bioscience, Eurofins Scientific, Thermo Fisher Scientific, Sartorius AG
www.marketwatch.com - March 14 at 10:44 AM |
| Did Lonza Group Ltd’s (VTX:LONN) Recent Earnings Growth Beat The Trend?
finance.yahoo.com - March 14 at 10:44 AM |
 | BRIEF-Lonza To Establish Cell- And Gene-Therapy Centers Of Excellence
www.reuters.com - February 14 at 4:40 PM |
| FY2018 EPS Estimates for Lonza Group Ag Reduced by Jefferies Group (LZAGY)
www.americanbankingnews.com - February 5 at 5:46 AM |
| Lonza Group Ag (LZAGY) Declares None Dividend of $0.26
www.americanbankingnews.com - February 2 at 11:14 AM |
| ETFs with exposure to Lonza Group AG : December 26, 2017
finance.yahoo.com - December 27 at 5:38 AM |
| Global Surface Disinfectant Chemicals Market Revenue to Cross US$ 4 Bn by 2027 End - Future Market Insights
www.marketwatch.com - November 3 at 4:13 PM |
 | 3D Cell Culture Market by Technology, Application, and End User - Global Industry Analysis and Forecast to 2025 Published by Crystal Market Research
globenewswire.com - October 16 at 8:02 PM |
| ETFs with exposure to Lonza Group AG : September 7, 2017
finance.yahoo.com - September 8 at 2:52 AM |
| Lonza Group AG :LZAGY-US: Earnings Analysis: For the six months ended June 30, 2017 : August 1, 2017
finance.yahoo.com - August 2 at 3:31 AM |
 | Lonza's (LZAGY) CEO Richard Ridinger on Q2 2017 Results - Earnings Call Transcript
seekingalpha.com - July 28 at 2:57 AM |
| Jefferies Group LLC Upgrades Lonza Group Ag (LZAGY) to Buy
www.americanbankingnews.com - July 19 at 5:00 PM |
 | Global Biocides Market Research Report - Industry Analysis, Size, Share, Growth, Trends and Forecast, 2014 - 2021
www.prnewswire.com - January 26 at 8:13 PM |
 | Lonza FY16 Core EBITDA Rises; Expects FY Sales Growth Of Mid-single Digits
www.rttnews.com - January 25 at 3:54 AM |
| Industrial and Institutional Cleaning Chemicals Market: Commercial Application ...
www.prnewswire.com - January 11 at 12:19 AM |
 | lonza group ag-unspon adr
www.bloomberg.com - January 8 at 6:08 PM |
 | Lonza concludes peptides business sale, books charges
uk.finance.yahoo.com - January 4 at 1:29 AM |
![[$$] Lonza buys capsule maker Capsugel for $5.5bn](/images/news-sites/yahoo.jpg "[$$] Lonza buys capsule maker Capsugel for $5.5bn") | [$$] Lonza buys capsule maker Capsugel for $5.5bn
us.rd.yahoo.com - December 15 at 7:02 PM |
![[$$] Drug Company Lonza to Buy Capsule Maker From KKR](/images/news-sites/wsj.jpg "[$$] Drug Company Lonza to Buy Capsule Maker From KKR") | [$$] Drug Company Lonza to Buy Capsule Maker From KKR
us.rd.yahoo.com - December 15 at 7:02 PM |
| Capsugel S.A. Luxembourg -- Moody's reviews Capsugel's ratings for upgrade on pending acquisition by Lonza
us.rd.yahoo.com - December 15 at 7:02 PM |
 | Lonza Group Buys KKR-Backed Capsugel in $5.5 Billion Healthcare Deal
www.thestreet.com - December 15 at 5:08 AM |
| [$$] Lonza to Buy Capsugel from KKR in Multibillion-Dollar Deal
www.wsj.com - December 15 at 5:08 AM |
| Exclusive: Lonza says in talks to buy Capsugel; deal could top $5 billion - sources
us.rd.yahoo.com - December 12 at 10:28 AM |
| European shares pull back but oil rally limits losses
us.rd.yahoo.com - December 12 at 10:28 AM |
| [$$] Lonza Confirms Talks to Buy Capsugel From KKR
us.rd.yahoo.com - December 12 at 10:28 AM |
| 7:02 am Lonza confirms interest in KKR's (KKR) Capsugel
us.rd.yahoo.com - December 12 at 10:28 AM |
Lonza Group (OTCMKTS:LZAGY) SEC Filings
This page is loading this company's SEC Filings. Please wait...
Financials are not available for this stock.
Lonza Group (OTCMKTS LZAGY) Stock Chart for Monday, April, 23, 2018
Loading chart…
